Joseph Musaazi

Biographic Data

ID7752708
NAMEJoseph Musaazi
GIVEN NAMESJoseph
FAMILY NAMEMusaazi
SIGNATUREMUSAAZI J
AFFILIATIONSInfectious Diseases Institute
ORCID0000-0001-5245-4571
VERIFIEDYes
TOTAL WORKS9
TOTAL CITATIONS0
AUTHOR COUNT9
EDITOR COUNT0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2026
H-INDEX0

  • The implementation of tuberculosis preventive therapy in HIV care clinics in Africa, Asia and Latin America

    Open AccessRemo Schmutz, Nicolas Banholzer et al.ARTICLEBMJ Global Health2026

    INTRODUCTION: Towards the 'End TB Strategy' targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy (TPT) for high-risk groups including people living with HIV (PLWH). 3 years after the release of the updated 2020 WHO guidelines, we investigated the implementation of TPT services at HIV clinics in low-income and middle-income countries (LMICs), focusing on TB screening, populations eligible for TPT and available TPT regi…

  • Preferences for long-acting injectable HIV pre-exposure prophylaxis service delivery among male and female sex workers in Uganda

    Open AccessRichard Muhindo, Rachel King et al.ARTICLEPLOS Global Public Health2025

    In Sub-Saharan Africa, limited data exist on the delivery of injectable HIV pre-exposure prophylaxis (PrEP). We explored service delivery preferences for injectable cabotegravir (CAB-LA) among heterosexual male sex workers (MSWs) and female sex workers (FSWs) in Uganda. We conducted a discrete choice experiment (DCE) among HIV-negative sex workers in two high HIV-prevalence Ugandan cities between October and December 2024. Participants selected f…

  • Knowledge, attitudes and practices towards tuberculosis

    Open AccessWilliam Kasozi, Edson Mwebesa et al.ARTICLEBMC Public Health2024

    More than two thirds of patients had good knowledge and practices towards TB which can be leveraged to improve uptake of TB control interventions in the region. Additional interventions to improve TB knowledge and practice should focus on specific segments within the communities e.g., older women in the households

  • Public perceptions of Ebola vaccines and confidence in health services to treat Ebola, malaria, and tuberculosis

    Open AccessAybüke Koyuncu, Rosalind J Carter et al.ARTICLEPLOS Global Public Health2023

    Uganda used Ebola vaccines as part of its preparedness and response during the 2018–2020 10 th Ebola virus disease (EVD) outbreak in neighboring Democratic Republic of the Congo (DRC). We evaluated the public’s perceptions of Ebola vaccines and compared their confidence in health services to treat Ebola versus malaria and tuberculosis as part of a survey on Ebola knowledge, attitudes, and practices (KAP) conducted in March 2020. A cross-sectional…

  • A case for routine microbial diagnostics

    Open AccessLaura Jung, James Kiwanuka et al.ARTICLEPLOS Global Public Health2023

    The global spread of antimicrobial resistance (AMR) poses an increasing challenge for clinicians in Uganda, where microbiological diagnostics are not routinely available or accessible. The aim of this study was to determine pathogen prevalence and antibiotic resistance patterns in patients with wound infections following trauma at a national referral hospital in Kampala, Uganda. In addition, the suitability of currently used empirical treatment o…

  • Integrating interferon-gamma release assay testing into provision of tuberculosis preventive therapy is feasible in a tuberculosis high burden resource-limited setting

    Open AccessSimon Muchuro, Rita Makabayi‐Mugabe et al.ARTICLEPLOS Global Public Health2022

    The World Health Organization recommends the scale-up of tuberculosis preventive therapy (TPT) for persons at risk of developing active tuberculosis (TB) as a key component to end the global TB epidemic. We sought to determine the feasibility of integrating testing for latent TB infection (LTBI) using interferon-gamma release assays (IGRAs) into the provision of TPT in a resource-limited high TB burden setting. We conducted a parallel convergent …

  • Adherence monitoring methods to measure virological failure in people living with HIV on long-term antiretroviral therapy in Uganda

    Open AccessStephen Okoboi, Joseph Musaazi et al.ARTICLEPLOS Global Public Health2022

    Appointment keeping and self-report within 7-day or and 30-days recall periods are non-objective measures of antiretroviral treatment (ART) adherence. We assessed incidence of virological failure (VF), predictive performance and associations of these adherence measures with VF among adults on long-term ART. Data for persons initiated on ART between April 2004 and April 2005, enrolled in a long-term ART cohort at 10-years on ART (baseline) and fol…

  • Incidence rate of sexually transmitted infections among HIV infected patients on long-term ART in an urban and a rural clinic in Uganda

    Open AccessStephen Okoboi, Barbara Castelnuovo et al.ARTICLEBMC Public Health2019

    We found STIs incidence rate of approximately 3 per 1000 person-years among patients on long-term (≥ 4 years) ART followed up-to 3.5 years. Rural and younger persons on ART should be routinely screened for STIs because high incidence of STIs may undo the preventative effects of ART for all

  • Different modalities of entry in a large urban clinic in Uganda and impact on outcomes of patients assessing HIV care and treatment

    Barbara Castelnuovo, Rachel Musomba et al.ARTICLEAIDS Care2017

    In resource-limited settings, a number of patients do not receive continuous HIV care. In this analysis, we compared outcomes in patients who entered care by different modality of entry. This was a retrospective analysis of all patients started on antiretroviral treatment (ART) at a large urban center in Uganda from 2005 to 2012. Patients were categorized into three groups (1) Front door: started on ART without interruption during follow-up; (2) …